BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 32020223)

  • 1. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis.
    Chen T; Lei S; Zeng Z; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
    Oncol Rep; 2020 Mar; 43(3):930-942. PubMed ID: 32020223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effect of LINC00261 upregulation on the pancreatic cancer EMT process is mediated by KLF13 via the mTOR signaling pathway.
    Li B; Pang S; Dou J; Zhou C; Shen B; Zhou Y
    Clin Transl Oncol; 2022 Jun; 24(6):1059-1072. PubMed ID: 35066757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA UCA1 impacts cell proliferation, invasion, and migration of pancreatic cancer through regulating miR-96/FOXO3.
    Zhou Y; Chen Y; Ding W; Hua Z; Wang L; Zhu Y; Qian H; Dai T
    IUBMB Life; 2018 Apr; 70(4):276-290. PubMed ID: 29500870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
    Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
    Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
    Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
    Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
    [No Abstract]   [Full Text] [Related]  

  • 6. Overexpression of LINC00261 inhibits non-small cell lung cancer cells progression by interacting with miR-522-3p and suppressing Wnt signaling.
    Shi J; Ma H; Wang H; Zhu W; Jiang S; Dou R; Yan B
    J Cell Biochem; 2019 Oct; 120(10):18378-18387. PubMed ID: 31190356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p.
    Wang X; Gao X; Tian J; Zhang R; Qiao Y; Hua X; Shi G
    Arch Biochem Biophys; 2020 Aug; 689():108469. PubMed ID: 32590069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00261 suppresses human colon cancer progression via sponging miR-324-3p and inactivating the Wnt/β-catenin pathway.
    Yan D; Liu W; Liu Y; Luo M
    J Cell Physiol; 2019 Dec; 234(12):22648-22656. PubMed ID: 31183860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
    Han Q; Li J; Xiong J; Song Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
    Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R
    Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3.
    Zou J; Pei X; Xing D; Wu X; Chen S
    J Cell Mol Med; 2021 Oct; 25(20):9826-9836. PubMed ID: 34541823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA GATA3‑AS1‑miR‑30b‑5p‑Tex10 axis modulates tumorigenesis in pancreatic cancer.
    Liu Y; Xu G; Li L
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway.
    Zhang J; Zhang K; Hou Y
    Mol Med Rep; 2020 Aug; 22(2):687-696. PubMed ID: 32468065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
    Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
    Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA LINC01124 activates hepatocellular carcinoma cell proliferation, migration, and invasion by absorbing microRNA-1247-5p and overexpressing FOXO3.
    Sun L; Zhang Y; Yao Y; DU H; Zhang Y; Fang A
    Oncol Res; 2021; 29(3):175-187. PubMed ID: 37304672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated long noncoding RNA Linc00261 in pre-eclampsia and its effect on trophoblast invasion and migration via regulating miR-558/TIMP4 signaling pathway.
    Cheng D; Jiang S; Chen J; Li J; Ao L; Zhang Y
    J Cell Biochem; 2019 Aug; 120(8):13243-13253. PubMed ID: 30891826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA DUXAP8 Promotes Pancreatic Carcinoma Cell Migration and Invasion Via Pathway by miR-448/WTAP/Fak Signaling Axis.
    Li JR; Liu L; Luo H; Chen ZG; Wang JH; Li NF
    Pancreas; 2021 Mar; 50(3):317-326. PubMed ID: 33625109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.